Login / Signup

Elevated liver enzymes at the time of deceased donor organ donation do not affect recipient or pancreas allograft survival following pancreas transplantation.

Evan M SoodFernando BomfimAbbigail DelmonteKendall DeSantisRosy JamesNaoru KoizumiRobert PlewsJorge Ortiz
Published in: HPB : the official journal of the International Hepato Pancreato Biliary Association (2024)
LFTs in the deceased pancreas donor did not increase risk of graft failure or mortality following pancreas transplantation. Elevated LFTs should not serve as absolute contraindications to transplant.
Keyphrases
  • kidney transplantation
  • cell therapy
  • stem cells
  • risk factors
  • coronary artery disease
  • cardiovascular disease
  • bone marrow